Effects of White Noise and Lullaby on Vital Signs of Term Newborns in Neonatal Intensive Care
Comparison of the Effects of White Noise and Lullaby on Vital Parameters in Term Infants Hospitalized in the Neonatal Intensive Care Unit: A Controlled Randomized Study
This clinical study aims to evaluate how two types of gentle sounds - white noise and a traditional Turkish lullaby ("Dandini Dandini Dastana") - affect the vital signs of term newborns cared for in the Neonatal Intensive Care Unit (NICU).
The first weeks of life are critical for newborns, especially those who need special care in the NICU. During this time, maintaining physiological stability-such as normal heart rate, breathing rate, and oxygen levels-is essential. In addition to medical treatments, non-pharmacological interventions like music and soothing sounds are increasingly used to reduce stress and support comfort.
In this randomized controlled study, 70 term newborns (born after 37 weeks of gestation and weighing at least 2500 grams) were randomly assigned to one of two groups:
- White Noise Group: infants listened to a digitally recorded white noise (imitating intrauterine sound patterns) for 20 minutes.
- Lullaby Group: infants listened to a recording of the traditional lullaby "Dandini Dandini Dastana" for the same duration.
Both interventions were administered three times a day for four consecutive days in a calm NICU environment. The sound level was carefully calibrated not to exceed 55 decibels (dBA), ensuring safety for newborn hearing.
Researchers measured heart rate, respiratory rate, and oxygen saturation (SpO₂) at baseline and at the 5th, 10th, 15th, and 20th minutes during each session.
Results showed that both white noise and lullaby sessions led to a gradual decrease in heart rate, while breathing rate and oxygen levels remained stable. No adverse events or signs of physiological instability were observed.
These findings suggest that both white noise and lullaby listening are safe, low-cost, and effective supportive methods for helping term newborns remain calm and physiologically stable during intensive care. The study contributes to growing evidence that structured auditory stimulation can help promote comfort and self-regulation in newborns without the need for medication.
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
Background and Rationale: Newborns admitted to the Neonatal Intensive Care Unit (NICU) are frequently exposed to environmental stressors that may disrupt autonomic stability. Developmental care strategies increasingly incorporate sensory modulation approaches to support physiological regulation. Auditory stimulation, including white noise and lullabies, has shown potential to reduce stress responses and promote behavioral organization. However, comparative evidence in term newborns remains limited, as most studies have focused on preterm populations. This study was designed to evaluate and compare the short-term physiological effects of two standardized auditory interventions-white noise and lullaby exposure-in term newborns under controlled NICU conditions.
Study Design and Setting: This was a prospective, multicenter, parallel-group randomized controlled trial conducted in two tertiary NICUs in Türkiye. Participants were randomized in a 1:1 ratio using stratified block randomization by center, with allocation concealment ensured through sealed opaque envelopes.
Intervention Protocols: Both interventions were delivered in a standardized manner to minimize environmental variability. Auditory stimulation sessions lasted 20 minutes and were administered three times daily over four consecutive days. Sound intensity was calibrated prior to each session and maintained below 55 dBA to ensure auditory safety. White noise exposure consisted of a digitally standardized recording simulating intrauterine acoustic patterns. The lullaby intervention consisted of a culturally familiar, standardized digital recording. All sessions were conducted during stable clinical conditions and scheduled to avoid routine caregiving activities. The playback device was a portable MP3 player with a 3-5 W speaker placed approximately 50 cm from the infant's ear. Sound intensity was measured before each session using a Wintact WT85 decibel meter, maintaining a maximum of 55 dBA (A-weighted). Sessions were conducted during quiet periods after routine care and feeding to minimize external stressors.
Data Collection and Measurements: Physiological parameters were obtained using continuous bedside monitoring systems. Heart rate and oxygen saturation were automatically recorded, while respiratory rate was assessed using standardized observation methods. Repeated measurements within sessions enabled evaluation of temporal trends and within-subject variability.
Statistical Analysis: The primary analytical approach utilized linear mixed-effects models to account for repeated measurements within individuals. Fixed effects included intervention group, time, and group-by-time interaction, while random intercepts accounted for within-subject correlation. Baseline values and study center were included as covariates. Sensitivity analyses were performed to assess the robustness of the findings.
Ethical Considerations: The study was approved by the institutional ethics committee, and written informed consent was obtained from parents or legal guardians prior to enrollment. All procedures were conducted in accordance with the Declaration of Helsinki.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Unzutreffend
Kontakte und Standorte
Studienorte
-
-
-
Istanbul, Türkei (türkiye)
- Başakşehir Çam and Sakura City Hospital
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Kind
Akzeptiert gesunde Freiwillige
Beschreibung
Inclusion Criteria:
- Gestational age ≥ 37 completed weeks
- Birth weight ≥ 2500 grams
- Postnatal age between 0 and 28 days at enrollment
- Admitted to the neonatal intensive care unit (NICU) for any medical reason
- Spontaneous breathing (not intubated)
- No current sedative or analgesic medication
- Written informed consent obtained from parents or legal guardians
Exclusion Criteria:
- Gestational age < 37 weeks (preterm infants)
- Birth weight < 2500 grams
- Congenital hearing loss or major congenital anomaly
- History of seizures or intracranial hemorrhage
- Requirement for mechanical ventilation
- Current use of sedative or analgesic drugs
- Early discharge or death before completion of the intervention protocol
- Parental refusal or withdrawal of consent during study procedures
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Unterstützende Pflege
- Zuteilung: Zufällig
- Interventionsmodell: Parallele Zuordnung
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: White Noise Group
Term newborns received a standardized white noise recording representing intrauterine sound characteristics ("Colic" album, Osman Orhan).
Each session lasted 20 minutes, conducted three times daily (at 11:00, 14:00, and 17:00) for four consecutive days.
The sound level was calibrated to a maximum of 55 dBA at the infant's ear level.
Heart rate, respiratory rate, and oxygen saturation were recorded at baseline and at the 5th, 10th, 15th, and 20th minutes during each session.
|
Participants listened to a digitally recorded standardized white noise stimulus mimicking intrauterine sound characteristics.
Each session lasted 20 minutes and was conducted three times daily (at 11:00, 14:00, and 17:00) for four consecutive days in the neonatal intensive care unit.
The sound level was measured and calibrated before each session to a maximum of 55 dBA at the infant's ear level using a decibel meter (Wintact WT85).
Heart rate, respiratory rate, and oxygen saturation were monitored at baseline and during the session.
The intervention was administered under stable clinical conditions after routine care.
|
|
Experimental: Lullaby Group
Term newborns listened to a digital recording of the traditional Turkish lullaby "Dandini Dandini Dastana."
Each session lasted 20 minutes, conducted three times daily (at 11:00, 14:00, and 17:00) for four consecutive days, under identical environmental conditions as the white noise group.
The sound intensity was standardized not to exceed 55 dBA.
Vital signs (heart rate, respiratory rate, oxygen saturation) were monitored at baseline and throughout the session.
|
Participants listened to a digital recording of the traditional Turkish lullaby "Dandini Dandini Dastana."
Sessions lasted 20 minutes and were conducted three times daily (11:00, 14:00, 17:00) for four consecutive days in the neonatal intensive care unit, identical to the white noise schedule.
The sound intensity was standardized to a maximum of 55 dBA.
Vital parameters (heart rate, respiratory rate, oxygen saturation) were recorded at baseline and at 5, 10, 15, and 20 minutes during each session.
The intervention aimed to promote relaxation and physiological stability in term newborns.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Heart Rate (beats per minute) from Baseline to 20th Minute During Intervention Session
Zeitfenster: Change from baseline to 20 minutes, averaged across intervention sessions over 4 days.
|
Heart rate (beats per minute) was continuously monitored using bedside patient monitors (Dräger, Germany).
The primary endpoint is the within-session change in heart rate from baseline to the 20th minute, averaged across all sessions over four days.
The measure assesses the acute physiological calming effect of auditory stimulation (white noise or lullaby) in term newborns.
|
Change from baseline to 20 minutes, averaged across intervention sessions over 4 days.
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Change in Oxygen Saturation (SpO₂, %) from Baseline to 20th Minute During Intervention Session
Zeitfenster: Change from baseline to 20 minutes, averaged across intervention sessions over 4 days.
|
Peripheral oxygen saturation (SpO₂, %) was continuously recorded using pulse oximetry as part of bedside monitoring.
The outcome assesses maintenance of oxygenation and physiological safety during auditory stimulation in term newborns.
|
Change from baseline to 20 minutes, averaged across intervention sessions over 4 days.
|
|
Incidence of Adverse Events During or Immediately After Intervention Sessions
Zeitfenster: During intervention and up to 30 minutes post-intervention, over 4 days.
|
Any clinically significant event (e.g., desaturation, apnea, bradycardia, or need for clinical intervention) occurring during or immediately after a session was documented according to NICU safety protocols.
This outcome assesses the tolerability and safety of auditory stimulation.
|
During intervention and up to 30 minutes post-intervention, over 4 days.
|
Mitarbeiter und Ermittler
Ermittler
- Hauptermittler: Nevin Cambaz Kurt, MD, Assoc. Prof., TC Health Sciences University, Basaksehir Cam and Sakura City Hospital
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Andere Studien-ID-Nummern
- 08.09.2025-39
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .